FDA Approved: RITUXAN HYCELA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved RITUXAN HYCELA (rituximab and hyaluronidase) under an Original Application by Genentech. The subcutaneous formulation provides an alternative to IV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis
• Non-hodgkin Lymphoma
• Rheumatoid Arthritis
• Small Lymphocytic Lymphoma

Drugs mentioned

• Rituxan Hycela (rituximab/hyaluronidase)

Snippet

ORIG AP for RITUXAN HYCELA (RITUXIMAB AND HYALURONIDASE)